DB

Debora Barton

Arovella Therapeutics Limited | Non-Executive Director
Dr Barton has over 20 years of oncology experience, which includes 9 years of clinical management of oncology patients and enrolling patients in clinical trials in academia. In the pharmaceutical industry, she has experience in medical affairs and clinical development in both large pharmaceutical and small biotech companies, including regulatory interactions in the USA, Europe, Australia, and several countries around the world.

Company and Role

Company
Title
Tenure
Since
ALA
ALA
Arovella Therapeutics Limited
  • Non-Executive Director
3yrs, 4mthAug 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ALA
ALA
Arovella Therapeutics Limited
26/11/24263,157N/A5,772,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ALA
ALA
Arovella Therapeutics Limited
26/11/24
Issued
354,000$0.185$65,490Director remuneration
ALA
ALA
Arovella Therapeutics Limited
04/12/23
Issued
618,000$0.088$54,384Director remuneration
ALA
ALA
Arovella Therapeutics Limited
15/12/22
Issued
2,400,000$0.025$60,000Director remuneration
ALA
ALA
Arovella Therapeutics Limited
16/03/22
Issued
263,157$0.038$9,999Placement
ALA
ALA
Arovella Therapeutics Limited
16/12/21
Issued
2,400,000$0.040$96,000Issue of options